The domestic brokerage firm said weak US business and INR appreciation against US dollar/Brazilian Real/Japanese Yen/ South African Rand are expected to drag earnings of Indian pharma companies. "US revenue expected to decline 11 per cent year-on-year for the sector in constant currency (CC), ...
Read more: Closing bell: Sensex ends up 184 pts; Nifty, Midcap at record close; Yes Bank gains 5%